Cyclophosphamide-induced antimetastatic immunomodulation in a rat lymphoma model
Matar, P.; Rozados, V.; Roggero, E.; Bonfil, R.D.; Scharovsky, O.G.
Proceedings of the American Association for Cancer Research 38: 119-120
1997
ISSN/ISBN: 0569-2261 Accession: 030771992
PDF emailed within 1 workday: $29.90
Related References
Matar, P.; Rozados, V.R.; Roggero, E.A.; Bonfil, R.D.; Scharovsky, O.G. 1998: Modulation of the antimetastatic effect of a single low dose of cyclophosphamide on rat lymphoma Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 19(2): 69-76Matar, P.; Rozados, V.R.; Gervasoni, S.I.; Scharovsky, G.O. 2002: Th2/Th1 switch induced by a single low dose of cyclophosphamide in a rat metastatic lymphoma model Cancer Immunology Immunotherapy: Cii 50(11): 588-596
Andrade-Mena, C.E. 1994: Cyclophosphamide-induced tumour regression of cyclophosphamide-resistant L5178Y lymphoma through suppressor cells elimination International Journal of Tissue Reactions 16(2): 95-103
Satake, H.; Takechi, T.; Nakano, K.; Saito, H.; Uchida, J.; Takeda, S.; Unemi, N.; Fukushima, M. 1996: Antimetastatic effects of UFT on murine liver metastasis model using L5178YHM lymphoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(14): 2001-2004
Papoian, R.; Roubinian, J.R.; Dauphinée, M.J.; Talal, N. 1980: The New Zealand mouse as a model for the therapy of human SLE: immunomodulation of murine lupus by sex hormones and cyclophosphamide Agents and Actions. Supplements 7: 41-45
Arlt, M.; Kopitz, C.; Pennington, C.; Watson, K.L.M.; Krell, H-Willi.; Bode, W.; Gansbacher, B.; Khokha, R.; Edwards, D.R.; Krüger, A. 2002: Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model Cancer Research 62(19): 5543-5550
Taraskina, N.P.; Iunker, V.M.; Surkova, O.I. 1990: Characteristics of metastasis and antimetastatic activity of macrophages in mice after postoperative immunomodulation Eksperimental'naia Onkologiia 12(4): 67-70
Kalinka-Warzocha, E.; Wajs, J.; Lech-Maranda, E.; Ceglarek, B.; Holowiecki, J.; Federowicz, I.; Walewski, J.; Czyz, J.; Robak, T.; Warzocha, K.; Centkowski, P.; Sulek, K.; Blasinska-Morawiec, M.; Stella-Holowiecka, B.; Mazur, G.; Jedrzejczak, W.; Watek, M.; Bilinski, P.; Kisiel, E. 2008: Randomized comparison of cladribine alone or in combination with cyclophosphamide, and cyclophosphamide, vincristine and prednisone in previously untreated low-grade B-cell non-Hodgkin lymphoma patients: final report of the Polish Lymphoma Research Group Cancer 113(2): 367-375
Mauceri, H.J.; Seetharam, S.; Beckett, M.A.; Schumm, L.P.; Kufe, D.W.; Weichselbaum, R.R. 2002: Angiostatin enhances the antimetastatic effects of cyclophosphamide Proceedings of the American Association for Cancer Research 43: 173
Matar, P.; Rozados, V.R.; González, A.D.; Dlugovitzky, D.G.; Bonfil, R.D.; Scharovsky, O.G. 2000: Mechanism of antimetastatic immunopotentiation by low-dose cyclophosphamide European Journal of Cancer 36(8): 1060-1066
Konovalova, N.P.; D'yachkovskaya, R.F.; Volkova, L.M.; Kagiya, V.T. 1994: Potentiation of the antimetastatic activity of cyclophosphamide radiosensitizer AK-2123 Eksperimental'naya Onkologiya 16(4-6): 419-422
Levy, M.Y.; Sidana, A.; Chowdhury, W.H.; Solomon, S.B.; Drake, C.G.; Rodriguez, R.; Fuchs, E.J. 2009: Cyclophosphamide unmasks an antimetastatic effect of local tumor cryoablation Journal of Pharmacology and Experimental Therapeutics 330(2): 596-601
Matar, P.; Gonzalez, A.; Rozados, V.R.; Dlugovitzky, D.; Bonfil, R.D.; Scharovsky, O.G. 1999: Immunomodulatory effect of a single-low dose of cyclophosphamide in a rat lymphoma model Proceedings of the American Association for Cancer Research 40: 183
Rabinovich, G.A.; Rubinstein, N.; Matar, P.; Rozados, V.; Gervasoni, S.; Scharovsky, G.O. 2002: The antimetastatic effect of a single low dose of cyclophosphamide involves modulation of galectin-1 and Bcl-2 expression Cancer Immunology Immunotherapy: Cii 50(11): 597-603
Osunkoya, B.O.; Ngu, V.A.; Mottram, F.C. 1970: Morphology of Burkitt's lymphoma during regression induced by cyclophosphamide Cancer 25(3): 505-509